10.1016/S0014-2999(98)00062-4
1998, J Pharmacol Exp Ther, 286, 1159
10.1097/00001756-199911260-00039
10.1016/0014-2999(95)00303-3
10.1111/j.1749-6632.1998.tb08227.x
10.1016/S0014-2999(01)01070-6
10.1016/0024-3205(88)90135-X
1961, J Pharm Pharmacol, 13, 701, 10.1111/j.2042-7158.1961.tb11896.x
2002, Br J Pharmacol, 135, 346P
2002, Neuropsychopharmacology, 26, 140
10.1177/014107689308600420
10.1016/0014-2999(88)90056-8
1987, J Pharmacol Exp Ther, 242, 911
Battaglia G, Zaczek R, and De Souza EB (1990) MDMA effects in brain: pharmacologic profile and evidence of neurotoxicity from neurochemical and autoradiographic studies, in Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA (Peroutka SJ ed) pp 171-190, Kluwer Academic Publishers, Norwalk, MA.
10.1016/0361-9230(94)90035-3
10.1016/0014-2999(92)90023-W
10.1017/S0033291701003828
1998, Biog Amines, 14, 217
10.1016/S0006-8993(01)03070-0
10.1016/S0014-2999(02)02420-2
1994, J Pharmacol Exp Ther, 271, 285
1995, J Pharmacol Exp Ther, 275, 325
2001, J Neurosci, 21, 3228, 10.1523/JNEUROSCI.21-09-03228.2001
1995, J Pharmacol Exp Ther, 274, 943
10.1001/jama.1987.03400060056020
10.1016/S0091-3057(00)00227-6
10.1016/0006-8993(94)91624-1
2001, Ann Med Interne, 152, 1S57
1998, Neuroreport, 9, 2691, 10.1097/00001756-199808240-00001
1990, J Pharmacol Exp Ther, 254, 456
10.1046/j.1471-4159.2002.00879.x
10.1007/s00204-002-0324-z
10.1177/014107689108400622
1946, J Pharmacol Exp Ther, 87, 214
1947, J Pharmacol Exp Ther, 89, 289
10.1002/(SICI)1522-2586(199910)10:4<521::AID-JMRI4>3.0.CO;2-9
10.1016/S0165-1781(00)00187-6
10.1016/S0014-2999(95)80103-0
10.1016/S0378-4274(99)00205-2
10.1016/0006-2952(95)02397-6
Cohen RS (1998) The Love Drug. Marching to the Beat of Ecstasy, Haworth Medical Press, Binghamton, NY.
10.1016/S0301-0082(96)00033-0
1994, Br J Pharmacol, 111, 131, 10.1111/j.1476-5381.1994.tb14034.x
10.1016/0014-2999(95)00298-Y
10.1111/j.1476-5381.1993.tb12846.x
10.1016/S0028-3908(98)00174-9
10.1111/j.1476-5381.1995.tb15037.x
1987, J Pharmacol Exp Ther, 241, 338
10.1016/S0162-3109(97)00084-2
1999, Hum Psychopharmacol, 14, 95, 10.1002/(SICI)1099-1077(199903)14:2<95::AID-HUP72>3.0.CO;2-7
1972, J Pharmacol Exp Ther, 180, 616
10.1111/j.1360-0443.1997.tb02951.x
10.1016/0031-9384(95)00136-7
2002, J Pharmacol Exp Ther, 300, 138
10.1002/(SICI)1099-1077(199705/06)12:3<221::AID-HUP854>3.0.CO;2-C
10.1046/j.1365-2125.2000.00121.x
2000, Ann NY Acad Sci, 914, 225, 10.1111/j.1749-6632.2000.tb05199.x
1997, Pharmacol Toxicol, 80, 207, 10.1111/j.1600-0773.1997.tb01961.x
10.1001/jama.1987.03390120077027
10.1016/S0922-4106(05)80027-6
10.1016/S0028-3908(00)00030-7
1999, Mol Brain Res, 71, 313, 10.1016/S0169-328X(99)00207-7
10.1016/S0091-3057(02)00728-1
1999, Clin Chem, 45, 1058, 10.1093/clinchem/45.7.1058
10.1007/s00213-002-1021-6
1995, J Pharmacol Exp Ther, 272, 860
10.1016/0006-8993(88)90974-2
1995, J Neurosci, 15, 5476, 10.1523/JNEUROSCI.15-08-05476.1995
1990, Chirality, 2, 241, 10.1002/chir.530020409
10.1016/0014-2999(90)94150-V
1994, J Pharm Pharmacol, 46, 826, 10.1111/j.2042-7158.1994.tb03738.x
10.1007/s00213-001-0931-z
10.1007/s00213-002-1071-9
10.1177/026988110101500406
1998, Ann NY Acad Sci, 44, 183
10.1016/0892-0362(95)00013-H
10.1016/0149-7634(95)00064-X
10.1016/S0893-133X(00)00130-5
1996, J Pharmacol Exp Ther, 279, 277
10.1016/S0006-3223(99)00180-8
10.1097/00004850-199801000-00001
1995, J Neurochem, 65, 1250, 10.1046/j.1471-4159.1995.65031250.x
10.1016/0091-3057(88)90034-2
1989, Neurotoxicology, 10, 455
1985, Br J Pharmacol, 84, 743, 10.1111/j.1476-5381.1985.tb16157.x
10.1016/0031-9384(94)90263-1
10.1016/0091-3057(91)90288-D
10.1016/0091-3057(91)90137-Q
1971, J Neurochem, 18, 1053, 10.1111/j.1471-4159.1971.tb12034.x
1971, Br J Pharmacol, 43, 854
1963, J Physiol (Lond), 167, 311, 10.1113/jphysiol.1963.sp007151
10.1016/S0163-7258(98)00024-2
1996, Br Med J, 312, 1493, 10.1136/bmj.312.7045.1493
1981, Br J Pharmacol, 73, 703, 10.1111/j.1476-5381.1981.tb16806.x
1976, Br J Pharmacol, 57, 141, 10.1111/j.1476-5381.1976.tb07664.x
2002, Psychopharmacology, 164, 448
1985, Am J Psychiatry, 142, 1391, 10.1176/ajp.142.11.1391
10.1016/0163-7258(95)98597-J
1986, Am J Psychotherapy, 40, 393, 10.1176/appi.psychotherapy.1986.40.3.393
10.1046/j.1471-4159.1996.66010243.x
10.1016/0014-2999(94)90669-6
1940, J Physiol (Lond), 97, 453, 10.1113/jphysiol.1940.sp003822
10.1016/S0014-2999(02)01820-4
1997, Free Radic Res, 27, 239, 10.3109/10715769709065762
10.1016/0891-5849(91)90052-5
10.1016/S0041-008X(73)80016-X
10.1016/S0024-3205(00)01039-0
10.1007/s00213-002-1131-1
10.1007/s00213-002-1265-1
10.1016/0006-8993(93)91590-O
1999, J Neurosci, 19, 5096, 10.1523/JNEUROSCI.19-12-05096.1999
10.1016/S0149-7634(98)00046-3
1981, J Pharmacol Exp Ther, 217, 745
10.1016/0304-3940(89)90351-0
10.1001/archpsyc.1984.01790150088012
10.1016/0140-6736(92)91469-O
10.1016/0028-3908(94)90134-1
1990, J Pharmacol Exp Ther, 254, 521
10.1016/0091-3057(89)90511-X
1988, Psychopharmacology, 95, 49
1995, Pharmacol Rev, 47, 133
10.1016/S0006-8993(99)02249-0
10.1016/S0006-8993(99)01663-7
10.1046/j.1471-4159.2001.00029.x
1989, J Pharmacol Exp Ther, 249, 713
1998, J Pharmacol Exp Ther, 284, 1040
10.1097/00001756-200009110-00022
Jacob JJ and Girault J-M (1979) 5-Hydroxytryptamine, in Body Temperature, Regulation, Drug Effects and Therapeutic Implications (Lomax P and Schonbaum E eds) pp 183-320, Marcel Dekker, Inc., New York.
10.1016/0014-2999(86)90615-1
10.1016/S0306-4522(98)00698-8
1988, J Pharmacol Exp Ther, 244, 977
1992, J Pharmacol Exp Ther, 261, 586
10.1016/S0006-8993(02)02310-7
10.1016/S0006-8993(00)02601-9
10.1016/S0006-8993(02)02313-2
10.1016/S0091-3057(97)00527-3
10.1016/0893-133X(95)00160-F
1992, J Pharmacol Exp Ther, 260, 78
10.1097/00004647-199601000-00012
10.1016/S0091-3057(01)00708-0
10.1016/0006-8993(89)90700-2
10.1016/S0014-2999(98)00741-9
1992, Am J Drug Alcohol Abuse, 18, 331, 10.3109/00952999209026070
1994, Mol Pharmacol, 45, 359
10.1016/0014-2999(90)93339-R
1994, Neuropsychopharmacology, 10, 231, 10.1038/npp.1994.26
1996, J Pharmacol Exp Ther, 276, 855
10.1016/S0893-133X(99)00148-7
10.1016/S0893-133X(00)00199-8
10.1016/S0893-133X(00)00126-3
10.1177/026988110001400313
10.1016/S0924-977X(00)00086-9
10.1016/S0091-3057(98)00191-9
10.1016/S0006-8993(96)01210-3
10.1016/0014-2999(88)90717-0
1987, Mol Pharmacol, 31, 194
1996, J Pharmacol Exp Ther, 278, 258
1998, J Neurosci, 18, 5086, 10.1523/JNEUROSCI.18-13-05086.1998
10.1016/S0091-3057(99)00116-1
10.1016/0014-2999(89)90746-2
10.1016/0006-8993(90)90889-J
1994, Br J Haematol, 88, 281, 10.1111/j.1365-2141.1994.tb05019.x
10.1016/S0893-133X(96)00240-0
1999, J Pharmacol Exp Ther, 290, 136
10.1016/S0378-4274(99)00207-6
10.1016/S0304-3940(01)01992-9
1991, J Clin Psychopharmacol, 11, 302
10.1016/0006-3223(92)90185-3
1993, J Clin Psychopharmacol, 13, 214
10.1016/S0893-133X(00)00171-8
10.2165/00002018-199615020-00003
10.1016/S0140-6736(98)04329-3
1999, J Pharmacol Exp Ther, 290, 965
10.1016/S0378-4274(99)00219-2
1993, Br J Psychiatry, 163, 698
1990, J Neurochem, 54, 14, 10.1111/j.1471-4159.1990.tb13277.x
10.1016/0091-3057(95)00206-C
10.1016/0165-1781(95)02701-W
10.1016/0006-3223(95)00301-V
10.1016/S0014-2999(97)00044-7
1994, J Pharmacol Exp Ther, 270, 752
Milton AS (1977) The hypothalamus and the pharmacology of thermoregulation, in Pharmacology of the Hypothalamus (Cox B, Morris ID, and Weston AH eds) The Macmillan Press Ltd., London.
1997, Ann NY Acad Sci, 813, 197, 10.1111/j.1749-6632.1997.tb51693.x
10.1111/j.1749-6632.1990.tb16916.x
1986, Soc Neurosci Abstr, 12, 1234
10.1016/0306-4522(95)00553-6
Mordenti J and Chappell W (1989) The use of interspecies scaling in toxicokinetics, in Toxicokinetics and New Drug Development (Yacogi A, Kelly J, and Batra V eds) pp 42-96, Pergamon Press, New York.
10.1016/S0378-4274(99)00217-9
10.1016/S0014-2999(01)01512-6
10.1016/S0014-2999(00)00749-4
10.1097/00001756-200110290-00026
10.1016/S0014-2999(02)01586-8
10.1016/S0028-3908(96)00118-9
1981, J Physiol (Lond), 77, 505
10.1016/0024-3205(90)90484-9
1991, J Pharmacol Exp Ther, 259, 820
1988, J Pharmacol Exp Ther, 245, 873
10.1016/0014-2999(91)90664-C
10.1016/0304-3940(94)90057-4
10.1016/0006-8993(92)90713-J
1996, J Neurochem, 67, 2521, 10.1046/j.1471-4159.1996.67062521.x
National Institute on Drug Abuse (NIDA) (2002). Monitoring the Future. National Survey Results on Drug Use, 1975-2001. Volume I: Secondary School Students, NIH Publication 02-5106. U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD.
10.1046/j.1471-4159.2001.00262.x
10.1016/S0165-0173(99)00019-3
10.1016/S0006-8993(97)01337-1
10.1016/S0031-9384(00)00235-3
1994, J Pharmacol Exp Ther, 270, 741
1988, J Neurosci, 8, 2788, 10.1523/JNEUROSCI.08-08-02788.1988
10.1016/S0278-5846(00)00179-2
10.1046/j.1471-4159.2002.00844.x
10.1016/S0028-3908(00)00106-4
10.1016/S0028-3908(98)00029-X
1991, Brain Res Bull, 28, 115
10.1177/026988119801200110
10.1016/S0376-8716(99)00146-5
10.1002/(SICI)1099-1077(199709/10)12:5<501::AID-HUP913>3.3.CO;2-M
1987, N Engl J Med, 317, 1542
1988, Neuropsychopharmacology, 1, 273
10.1016/0006-8993(90)91222-3
10.1001/archpsyc.1989.01810010022003
2003, Br J Pharmacol, 138, 197P
10.1016/S0014-2999(01)01118-9
1991, Essays Biochem, 26, 77
10.1016/0091-3057(95)02020-9
10.1016/S0140-6736(01)06888-X
10.1007/s00213-001-0930-0
10.1016/S0893-133X(01)00366-9
2000, Am J Neuroradiol, 21, 1001
2002, Am J Neuroradiol, 23, 231
1988, Brain Res, 474, 2359
10.1016/0006-8993(88)91309-1
10.1001/jama.1988.03410010059035
1992, J Pharmacol Exp Ther, 261, 616
1992, Ann NY Acad Sci, 648, 371, 10.1111/j.1749-6632.1992.tb24586.x
10.1016/S0378-4274(99)00216-7
10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3
1996, Brain Res Mol Brain Res, 37, 105, 10.1016/0169-328X(95)00284-Y
10.1016/0006-8993(93)90057-T
10.1002/(SICI)1096-9896(199703)181:3<255::AID-PATH757>3.0.CO;2-T
1996, J Pharmacol Exp Ther, 276, 846
10.1016/S0006-8993(98)00720-3
10.1016/S0149-7634(97)00029-8
1998, Pharmacol Toxicol, 82, 122, 10.1111/j.1600-0773.1998.tb01410.x
10.1016/S0028-3908(02)00411-2
1993, J Pharmacol Exp Ther, 264, 1484
10.1016/0028-3908(92)90126-A
10.1002/(SICI)1098-2396(199806)29:2<183::AID-SYN9>3.0.CO;2-3
1987, J Pharmacol Exp Ther, 240, 1
10.1016/0014-2999(87)90782-5
1990, J Pharmacol Exp Ther, 255, 478
10.1016/0006-8993(90)90813-Q
10.1016/0014-2999(90)90245-2
1990, Ann NY Acad Sci, 600, 665, 10.1111/j.1749-6632.1990.tb16917.x
10.1016/0006-2952(87)90729-5
10.1016/0006-2952(87)90566-1
10.1016/0014-2999(88)90154-9
1991, J Pharmacol Exp Ther, 256, 230
10.1016/0014-2999(86)90140-8
10.1016/S0091-3057(98)00103-8
10.1016/S0014-2999(99)00728-1
10.1046/j.1471-4159.1999.0722516.x
10.1002/1098-2396(200104)40:1<55::AID-SYN1026>3.0.CO;2-O
10.1016/0361-9230(92)90252-S
10.1016/S0014-2999(00)00521-5
Shulgin AT and Nichols DE (1978) Characterization of three new psychomimetics, in The Psychopharmacology of Hallucinogens (Stillman RC and Willette RE eds), Pergamon Press, Oxford.
10.1001/archinte.1981.00340120115023
1988, Toxicol Appl Pharmacol, 96, 448
1989, Neurotoxicology, 10, 529
10.1111/j.1360-0443.1992.tb02003.x
10.1017/S0140525X00022871
10.1016/0091-3057(89)90044-0
1998, Neurotoxicology, 19, 427
1995, J Pharmacol Exp Ther, 273, 667
10.1016/0006-2952(87)90594-6
1999, J Clin Psychiatry, 60, 485
10.1016/S0306-4522(99)00049-4
10.1016/0014-2999(87)90150-6
10.1016/0892-0362(91)90022-O
10.1016/0028-3908(87)90017-7
10.1016/0014-2999(87)90173-7
1988, J Pharmacol Exp Ther, 247, 79
10.1016/0922-4106(89)90048-5
10.1016/0028-3908(87)90117-1
10.1016/0014-2999(86)90555-8
10.1016/S1054-139X(01)00315-9
10.1016/S0014-2999(01)01386-3
2002, J Nucl Med, 43, 678
1995, J Cereb Blood Flow Metab, 15, 798, 10.1038/jcbfm.1995.100
10.1016/S0893-133X(00)00185-8
1984, Eur J Pharmacol, 76, 81
10.1016/0006-2952(94)90386-7
10.1007/s00213-001-0995-9
10.1016/S0893-133X(98)00013-X
10.1016/S0893-133X(00)00170-6
10.1007/s00213-002-1238-4
10.1016/S0140-6736(96)03410-1
1989, Am J Psychiatry, 146, 119
10.1016/0028-3908(89)90128-7
10.1016/S0376-8716(96)01324-5
10.1016/0306-4522(89)90237-6
10.1007/s00213-001-0942-9
10.1016/S0376-8716(00)00215-5
1973, J Pharm Pharmacol, 25, 425, 10.1111/j.2042-7158.1973.tb10044.x
10.1016/0014-2999(88)90564-X
1995, J Pharmacol Exp Ther, 273, 1063
1983, J Pharmacol Exp Ther, 227, 383
10.1016/S0091-3057(97)90010-1
1999, Synapse, 31, 169, 10.1002/(SICI)1098-2396(19990301)31:3<169::AID-SYN1>3.0.CO;2-N
10.1016/0091-3057(91)90165-X
10.1046/j.1471-4159.2001.00339.x
10.1046/j.0022-3042.2002.00758.x
1990, J Neurochem, 54, 195, 10.1111/j.1471-4159.1990.tb13301.x
10.1016/S0006-8993(98)00313-8
10.1001/jama.1986.03380220011003
